Findings underscore the risk for graded exercise in people with post-exertional malaise and point to careful activity pacing as a safer approach.

Medera has completed patient dosing in Cohort B of its ongoing MUSIC-HFpEF Phase I/IIa study of SRD-002 for heart failure ...

Background Inflammatory bowel disease (IBD) patients in China exhibit critically low levels of physical activity, yet evidence for telemedicine-based aerobic exercise interventions remains scarce, ...

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the final patient has ...

Background Axial spondyloarthritis (axSpA) impairs trunk strength, mobility and cardiorespiratory fitness. Despite exercise ...

The MAPLE-HCM trial showed that, among patients with symptomatic obstructive HCM, aficamten monotherapy was superior to metoprolol monotherapy in improving peak oxygen uptake and hemodynamics, and in ...

Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a new clinical trial shows. A nine-month program of supervised aerobic and ...

Randomized controlled trials have demonstrated that supervised exercise therapy improves functional status, walking performance, and quality of life in patients with peripheral artery disease (PAD) ...

Please provide your email address to receive an email when new articles are posted on . “In addition to patient-reported outcome measures (PROMs), an emerging concept in evaluating the treatment ...

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...